Fundraising FoxCambium Biomaterials, Inc.
El Segundo, US · Founded 2019 · Delaware corporation · 1 known investors
Find your way into Cambium Biomaterials, Inc.
Sign up to see every warm intro you have to Cambium Biomaterials, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cambium Biomaterials, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SH
SW
Simon WaddingtonExecutive
JG
James GriffinExecutiveJames Griffin is an executive officer at Cambium Biomaterials with expertise in polymer science, composite and adhesive development, and manufacturing process improvement. He has led material qualification programs for aerospace and consumer electronics companies and applied Lean and Six Sigma methodologies across manufacturing and R&D environments.
NM
Nic MadrenExecutiveNic Madren is an Executive Officer at Cambium Biomaterials developing synthetic biology and advanced materials products. He served 20 years as a naval aviator with experience in DoD acquisition, aerospace operations, and organizational strategy, and holds an MBA and BS in Physics from the Naval Postgraduate School and Naval Academy respectively.
AG
TG
Tim GardnerNamed on SEC filing
Board
Investors · 1
Reported raises · per SEC filings
Form D private placements$119.7M disclosed across 3 rounds · 2021–2025
▶$94.4MraisedDec 2025 · 33 investors · Other TechnologyRule 506(b)
▶$94.4MraisedDec 2025 · 33 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher PedersonDirector
- Brett SchneiderDirector
- Francisco GimenezDirector
- Tim GardnerExecutive Officer
- Stephan HerreraExecutive Officer
- Simon WaddingtonExecutive Officer, Director
- James GriffinExecutive Officer
- Nic MadrenExecutive Officer
- Offering amount
- $101.4M
- Amount sold
- $94.4M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17.4MraisedNov 2023 · 16 investors · Other TechnologyRule 506(b)
▶$17.4MraisedNov 2023 · 16 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Eliot PenceExecutive Officer
- Stephan HerreraExecutive Officer
- Simon WaddingtonExecutive Officer, Director
- Francisco GimenezDirector
- Offering amount
- $20M
- Amount sold
- $17.4M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$8MraisedSep 2021 · 3 investors · Other TechnologyRule 506(b)
▶$8MraisedSep 2021 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- ANDREW GUENTHNERExecutive Officer
- FRANCISCO GIMENEZDirector
- STEPHAN HERRERAExecutive Officer, Director
- SIMON WADDINGTONExecutive Officer, Director
- Offering amount
- $28M
- Amount sold
- $8M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Cambium Biomaterials, Inc.'s investors?
- Cambium Biomaterials, Inc.'s investors include 8VC.
- How much funding has Cambium Biomaterials, Inc. raised?
- Cambium Biomaterials, Inc. has disclosed $119.7M raised across 3 rounds.
- Where is Cambium Biomaterials, Inc. headquartered?
- Cambium Biomaterials, Inc. is headquartered in El Segundo, US.